perinatologyРоссийский вестник перинатологии и педиатрииRossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)1027-40652500-2228Ltd. “The National Academy of Pediatric Science and Innovation”10.21508/1027-4065-2026-71-2-18-24perinatology-2375Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSСовременное представление о кардиоренальном синдроме у детейCurrent understanding of cardiorenal syndrome in childrenhttps://orcid.org/0000-0002-4686-3245ПахомовА. П.PakhomovA. P.

Пахомов Антон Павлович — ассистент кафедры поликлинической педиатрии

460014, г. Оренбург, ул. Советская, дом 6 

460014, Orenburg 

anpakhomov@bk.ruhttps://orcid.org/0000-0001-7948-6661ЗоринИ. В.ZorinI. V.

Зорин Игорь Владимирович — д.м.н., доцент, заведующий кафедрой поликлинической педиатрии

460014, г. Оренбург, ул. Советская, дом 6 

460014, Orenburg 

zorin2000@yandex.ruФГБОУ ВО «Оренбургский государственный медицинский университет» Минздрава РоссииРоссияOrenburg State Medical UniversityRussian Federation2026250420267121824Copyright © Ltd. “The National Academy of Pediatric Science and Innovation”, 20262026Ltd. “The National Academy of Pediatric Science and Innovation”Ltd. “The National Academy of Pediatric Science and Innovation”https://www.ped-perinatology.ru/jour/about/submissions#copyrightNoticehttps://www.ped-perinatology.ru/jour/article/view/2375

Кардиоренальный синдром — это нарушение функции сердца и почек, при котором острое или хроническое повреждение одного из указанных органов может вызвать острое или хроническое повреждение другого. Несмотря на существующие исследования, проблема кардиоренального синдрома остается недостаточно изученной. Кардиоренальный синдром у детей имеет уникальные патогенетические механизмы и клинические проявления, требующие отдельного внимания. Также имеет место отсутствие стандартизированных подходов к диагностике кардиоренального синдрома у детей. В статье представлены различные подходы к классификации, эволюция концепции взаимоотношений между сердцем и почками, а также отражены современные представления о патогенезе кардиоренального синдрома.

Cardiorenal syndrome is a disorder of the heart and kidneys, in which acute or chronic damage to one of these organs can cause acute or chronic damage to the other organ. Despite existing research, the problem of cardiorenal syndrome remains insufficently studied. Cardiorenal syndrome in children has unique pathogenetic mechanisms and clinical manifestations that require special attention. There is also a lack of standardized diagnostic approaches in children. The article presents various approaches to classification, the evolution of the concept of cardiorenal relationships, and the current understanding of the pathogenesis of cardiorenal syndrome.

детикардиоренальный синдромхроническая сердечная недостаточностьхроническая болезнь почекchildrencardiorenal syndromechronic cardiac failurechronic kidney diseaseReferencesRonco C., House A.A., Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 2008; 34(5): 957–62. DOI: 10.1007/s00134-008-1017-8Ronco C., House A.A., Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 2008; 34(5): 957–62. DOI: 10.1007/s00134-008-1017-8Кобалава Ж.Д., Виллевальде С.В., Ефремовцева М.А., Моисеев В.С. Кардиоренальные взаимоотношения: современные представления. Кардиоваскулярная терапия и профилактика. 2010; 9(4): 4–11.Kobalava Zh.D., Villewalde S.V., Efremovtseva M.A., Moiseev V.S. Cardio-renal interrelation: modern view. Kardiovaskulyarnaya terapiya i profilaktika. 2010; 9(4): 4–11. (in Russ.).Ronco C., Haapio M., House A.A., Anavekar N., Bellomo R., Cardiorenal syndrome, J. Am. Coll. Cardiol. 2008; 52(19): 1527–1539. DOI: 10.1016/j.jacc.2008.07.051Ronco C., Haapio M., House A.A., Anavekar N., Bellomo R., Cardiorenal syndrome, J. Am. Coll. Cardiol. 2008; 52(19): 1527–1539. DOI: 10.1016/j.jacc.2008.07.051Резник Е.В., Никитин И.Г. Кардиоренальный синдром у больных с сердечной недостаточностью как этап кардиоренального континуума (часть I): определение, классификация, патогенез, диагностика, эпидемиология (обзор литературы). Архивъ внутренней медицины. 2019; 9(1): 5–22. DOI: 10.20514/2226-6704-2019-9-1-5-22Reznik E.V., Nikitin I.G. Сardiorenal syndrome in patients with chronic heart failure as a stage of the cardiorenal continuum (part I): definition, classification, pathogenesis, diagnosis, epidemiology. Arhiv” vnutrennej mediciny. 2019; 9(1): 5–22 / (in Russ.). DOI: 10.20514/2226-6704-2019-9-1-5-22Kula A.J., Bartlett D. Cardiorenal syndrome: evolving concepts and pediatric knowledge gaps. Pediatr Nephrol. 2025; 40(3): 651–660. DOI: 10.1007/s00467-024-06517-zKula A.J., Bartlett D. Cardiorenal syndrome: evolving concepts and pediatric knowledge gaps. Pediatr Nephrol. 2025; 40(3): 651–660. DOI: 10.1007/s00467-024-06517-zCeravolo G., Macchia T., Cuppari C., Dipasquale V., Gambadauro A., Casto C. et al. Update on the Classification and Pathophysiological Mechanisms of Pediatric Cardiorenal Syndromes. Children (Basel). 2021; 8(7): 528. DOI: 10.3390/children8070528Ceravolo G., Macchia T., Cuppari C., Dipasquale V., Gambadauro A., Casto C. et al. Update on the Classification and Pathophysiological Mechanisms of Pediatric Cardiorenal Syndromes. Children (Basel). 2021; 8(7): 528. DOI: 10.3390/children8070528Эрман М.В., Первунина Т.М., Моисеева О.М. Эпидемиология кардиоренального синдрома у детей. Нефрология. 2012; 16(4): 62–68. DOI: 10.24884/1561-6274-2012-16-4-62-68Erman M.V., Pervunina T.M., Moiseeva O.M. Pediatric cardiorenal syndrome epidemiology. Nefrologiya. 2012;16(4):62–68 (in Russ.). DOI: 10.24884/1561-6274-2012-16-4-62-68Zannad F., Rossignol P. Cardiorenal Syndrome Revisited. Circulation. 2018; 138(9): 929–944. DOI: 10.1161/CIRCULATIONAHA.117.028814Zannad F., Rossignol P. Cardiorenal Syndrome Revisited. Circulation. 2018; 138(9): 929–944. DOI: 10.1161/CIRCULATIONAHA.117.028814Zhang Y., Jiang Y., Yang W., Shen L., He B. Chronic Secondary Cardiorenal Syndrome: The Sixth Innovative Subtype. Front Cardiovasc Med. 2021; 8: 639959. DOI: 10.3389/fcvm.2021.639959Zhang Y., Jiang Y., Yang W., Shen L., He B. Chronic Secondary Cardiorenal Syndrome: The Sixth Innovative Subtype. Front Cardiovasc Med. 2021; 8: 639959. DOI: 10.3389/fcvm.2021.639959Kazory A., Ronco C. Advances in Cardiorenal Medicine: The Year 2023 in Review. Cardiorenal Med. 2024; 14(1): 123–128. DOI: 10.1159/000537785Kazory A., Ronco C. Advances in Cardiorenal Medicine: The Year 2023 in Review. Cardiorenal Med. 2024; 14(1): 123–128. DOI: 10.1159/000537785Арабидзе Г.Г., Мамедов М.Н. Кардиоваскулярно-почечно-метаболический синдром — новая концепция ассоциации факторов риска и нарушений обмена в рамках сердечно-сосудистого и почечного континуума. Мнение по проблеме. Российский кардиологический журнал. 2024;29(5):5772. DOI: 10.15829/1560-4071-2024-5772Arabidze G.G., Mamedov M.N. Cardiovascular-kidney-metabolic syndrome — a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue. Russian Journal of Cardiology. 2024;29(5):5772. (in Russ.). DOI: 10.15829/1560-4071-2024-5772Abreu A.P., Drager L.F., Almeida M.Q., Bortolotto L.A., Lopes H.F. Cardiovascular-kidney-metabolic Syndrome: a current and urgent concept. J Bras Nefrol. 2025; 47(2): e20240277. DOI: 10.1590/2175-8239-JBN-2024-0277enAbreu A.P., Drager L.F., Almeida M.Q., Bortolotto L.A., Lopes H.F. Cardiovascular-kidney-metabolic Syndrome: a current and urgent concept. J Bras Nefrol. 2025; 47(2): e20240277. DOI: 10.1590/2175-8239-JBN-2024-0277enNdumele C.E., Rangaswami J., Chow S.L., Neeland I.J., Tuttle K.R., Khan S.S. et al. American Heart Association. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023; 148(20): 1606–1635. DOI: 10.1161/CIR.0000000000001184Ndumele C.E., Rangaswami J., Chow S.L., Neeland I.J., Tuttle K.R., Khan S.S. et al. American Heart Association. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023; 148(20): 1606–1635. DOI: 10.1161/CIR.0000000000001184Rowntree LG, Fitz R, Geraghty JT. The effects of experimental chronic passive congestion on renal function. Arch Intern Med (Chic). 1913; XI(2): 121–147. DOI:10.1001/archinte.1913.00060260002001Rowntree LG, Fitz R, Geraghty JT. The effects of experimental chronic passive congestion on renal function. Arch Intern Med (Chic). 1913; XI(2): 121–147. DOI:10.1001/archinte.1913.00060260002001Xu X., Zhang B., Wang Y., Shi S., Lv J., Fu Z. et al. Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities. Biomed Pharmacother. 2023; 164: 114901. DOI: 10.1016/j.biopha.2023.114901Xu X., Zhang B., Wang Y., Shi S., Lv J., Fu Z. et al. Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities. Biomed Pharmacother. 2023; 164: 114901. DOI: 10.1016/j.biopha.2023.114901Basile D.P. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 2007; 72(2): 151–6. DOI: 10.1038/sj.ki.5002312Basile D.P. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 2007; 72(2): 151–6. DOI: 10.1038/sj.ki.5002312Virzì G.M., Clementi A., Battaglia G.G., Ronco C. MultiOmics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes. Cardiorenal Med. 2019; 9(4): 201–211. DOI: 10.1159/000497748Virzì G.M., Clementi A., Battaglia G.G., Ronco C. MultiOmics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes. Cardiorenal Med. 2019; 9(4): 201–211. DOI: 10.1159/000497748Virzì G.M., Zhang J., Nalesso F., Ronco C., McCullough P.A. The Role of Dendritic and Endothelial Cells in Cardiorenal Syndrome. Cardiorenal Med. 2018; 8(2): 92–104. DOI: 10.1159/000485937Virzì G.M., Zhang J., Nalesso F., Ronco C., McCullough P.A. The Role of Dendritic and Endothelial Cells in Cardiorenal Syndrome. Cardiorenal Med. 2018; 8(2): 92–104. DOI: 10.1159/000485937Zhang J., Bottiglieri T., McCullough P.A. The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome. Cardiorenal Med. 2017; 7(2): 104–117. DOI: 10.1159/000452283Zhang J., Bottiglieri T., McCullough P.A. The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome. Cardiorenal Med. 2017; 7(2): 104–117. DOI: 10.1159/000452283Liberale L., Badimon L., Montecucco F., Lüscher T.F., Libby P., Camici G.G. Inflammation, Aging, and Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2022; 79(8): 837–847. DOI: 10.1016/j.jacc.2021.12.017Liberale L., Badimon L., Montecucco F., Lüscher T.F., Libby P., Camici G.G. Inflammation, Aging, and Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2022; 79(8): 837–847. DOI: 10.1016/j.jacc.2021.12.017Akhter M.S., Goodwin J.E. Endothelial Dysfunction in Cardiorenal Conditions: Implications of Endothelial Glucocorticoid Receptor-Wnt Signaling. Int J Mol Sci. 2023; 24(18): 14261. DOI: 10.3390/ijms241814261Akhter M.S., Goodwin J.E. Endothelial Dysfunction in Cardiorenal Conditions: Implications of Endothelial Glucocorticoid Receptor-Wnt Signaling. Int J Mol Sci. 2023; 24(18): 14261. DOI: 10.3390/ijms241814261Guyton A.C. The surprising kidney-fluid mechanism for pressure control--its infinite gain! Hypertension. 1990; 16(6): 725–30. DOI: 10.1161/01.hyp.16.6.725Guyton A.C. The surprising kidney-fluid mechanism for pressure control--its infinite gain! Hypertension. 1990; 16(6): 725–30. DOI: 10.1161/01.hyp.16.6.725Matsuura R., Yamashita T., Hayase N., Hamasaki Y., Noiri E., Numata G. et al. Preexisting heart failure with reduced ejection fraction attenuates renal fibrosis after ischemia reperfusion via sympathetic activation. Sci Rep. 2021; 11(1): 15091. DOI: 10.1038/s41598-021-94617-3Matsuura R., Yamashita T., Hayase N., Hamasaki Y., Noiri E., Numata G. et al. Preexisting heart failure with reduced ejection fraction attenuates renal fibrosis after ischemia reperfusion via sympathetic activation. Sci Rep. 2021; 11(1): 15091. DOI: 10.1038/s41598-021-94617-3Zakeri R., Sangaralingham S.J., Sandberg S.M., Heublein D.M., Scott C.G., Burnett J.C. Jr. Urinary C-type natriuretic peptide: a new heart failure biomarker. JACC Heart Fail. 2013; 1(2): 170–7. DOI: 10.1016/j.jchf.2012.12.003Zakeri R., Sangaralingham S.J., Sandberg S.M., Heublein D.M., Scott C.G., Burnett J.C. Jr. Urinary C-type natriuretic peptide: a new heart failure biomarker. JACC Heart Fail. 2013; 1(2): 170–7. DOI: 10.1016/j.jchf.2012.12.003Ljungman S., Laragh J.H., Cody R.J. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs. 1990; 39 (4): 10–21. DOI: 10.2165/00003495-199000394-00004Ljungman S., Laragh J.H., Cody R.J. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs. 1990; 39 (4): 10–21. DOI: 10.2165/00003495-199000394-00004Ichikawa I., Pfeffer J.M., Pfeffer M.A., Hostetter T.H., Brenner B.M. Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res. 1984; 55(5): 669–75. DOI: 10.1161/01.res.55.5.669Ichikawa I., Pfeffer J.M., Pfeffer M.A., Hostetter T.H., Brenner B.M. Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res. 1984; 55(5): 669–75. DOI: 10.1161/01.res.55.5.669Rea M.E., Dunlap M.E. Renal hemodynamics in heart failure: implications for treatment. Curr Opin Nephrol Hypertens. 2008; 17(1): 87–92. DOI: 10.1097/MNH.0b013e3282f357daRea M.E., Dunlap M.E. Renal hemodynamics in heart failure: implications for treatment. Curr Opin Nephrol Hypertens. 2008; 17(1): 87–92. DOI: 10.1097/MNH.0b013e3282f357daRatnasamy C., Kinnamon D.D., Lipshultz S.E., Rusconi P. Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J. 2008; 155(3): 527–33. DOI: 10.1016/j.ahj.2007.11.001Ratnasamy C., Kinnamon D.D., Lipshultz S.E., Rusconi P. Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J. 2008; 155(3): 527–33. DOI: 10.1016/j.ahj.2007.11.001Blake WD, Wegria R et al. Effect of increased renal venous pressure on renal function. Am J Physiol. 1949 Apr;157(1):1–13. DOI: 10.1152/ajplegacy.1949.157.1.1. PMID: 18130215Blake WD, Wegria R et al. Effect of increased renal venous pressure on renal function. Am J Physiol. 1949 Apr;157(1):1–13. DOI: 10.1152/ajplegacy.1949.157.1.1. PMID: 18130215Verbrugge F.H., Dupont M., Steels P., Grieten L., Malbrain M., Tang W.H., Mullens W. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013; 62(6): 485–95. DOI: 10.1016/j.jacc.2013.04.070Verbrugge F.H., Dupont M., Steels P., Grieten L., Malbrain M., Tang W.H., Mullens W. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013; 62(6): 485–95. DOI: 10.1016/j.jacc.2013.04.070House A.A., Anand I., Bellomo R., Cruz D., Bobek I., Anker S.D. et al. Acute Dialysis Quality Initiative Consensus Group. Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010; 25(5): 1416–20. DOI: 10.1093/ndt/gfq136House A.A., Anand I., Bellomo R., Cruz D., Bobek I., Anker S.D. et al. Acute Dialysis Quality Initiative Consensus Group. Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010; 25(5): 1416–20. DOI: 10.1093/ndt/gfq136Campbell R.C., Sui X., Filippatos G., Love T.E., Wahle C., Sanders P.W. et al. Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study. Nephrol Dial Transplant. 2009; 24(1): 186–93. DOI: 10.1093/ndt/gfn445Campbell R.C., Sui X., Filippatos G., Love T.E., Wahle C., Sanders P.W. et al. Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study. Nephrol Dial Transplant. 2009; 24(1): 186–93. DOI: 10.1093/ndt/gfn445Raina R., Nair N., Chakraborty R., Nemer L., Dasgupta R., Varian K. An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome. Cardiol Res. 2020; 11(2): 76–88. DOI: 10.14740/cr95Raina R., Nair N., Chakraborty R., Nemer L., Dasgupta R., Varian K. An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome. Cardiol Res. 2020; 11(2): 76–88. DOI: 10.14740/cr95Hillege H.L., Nitsch D., Pfeffer M.A., Swedberg K., McMurray J.J., Yusuf S. et al. Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113(5): 671–8. DOI: 10.1161/CIRCULATIONAHA.105.580506Hillege H.L., Nitsch D., Pfeffer M.A., Swedberg K., McMurray J.J., Yusuf S. et al. Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113(5): 671–8. DOI: 10.1161/CIRCULATIONAHA.105.580506Ronco C., Bellasi A., Di Lullo L. Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018; 25(5): 382– 390. DOI: 10.1053/j.ackd.2018.08.004Ronco C., Bellasi A., Di Lullo L. Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018; 25(5): 382– 390. DOI: 10.1053/j.ackd.2018.08.004Zarbock A., Küllmar M., Ostermann M., Lucchese G., Baig K., Cennamo A. et al. Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analg. 2021; 133(2): 292–302. DOI: 10.1213/ANE.0000000000005458Zarbock A., Küllmar M., Ostermann M., Lucchese G., Baig K., Cennamo A. et al. Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analg. 2021; 133(2): 292–302. DOI: 10.1213/ANE.0000000000005458Angelini A., Castellani C., Virzì G.M., Fedrigo M., Thiene G., Valente M. et al. The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure. Cardiorenal Med. 2015; 6(1): 61–72. DOI: 10.1159/000440775Angelini A., Castellani C., Virzì G.M., Fedrigo M., Thiene G., Valente M. et al. The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure. Cardiorenal Med. 2015; 6(1): 61–72. DOI: 10.1159/000440775Hundae A., McCullough P.A. Cardiac and renal fibrosis in chronic cardiorenal syndromes. Nephron Clin Pract. 2014; 127(1–4): 106–12. DOI: 10.1159/000363705Hundae A., McCullough P.A. Cardiac and renal fibrosis in chronic cardiorenal syndromes. Nephron Clin Pract. 2014; 127(1–4): 106–12. DOI: 10.1159/000363705Hao H., Ma S., Zheng C., Wang Q., Lin H., Chen Z. et al. Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome. Aging (Albany NY). 2021; 13(2): 2982–3009. DOI: 10.18632/aging.202448Hao H., Ma S., Zheng C., Wang Q., Lin H., Chen Z. et al. Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome. Aging (Albany NY). 2021; 13(2): 2982–3009. DOI: 10.18632/aging.202448Breidthardt T., Cox E.F., Squire I., Odudu A., Omar N.F., Eldehni M.T. et al. The pathophysiology of the chronic cardiorenal syndrome: a magnetic resonance imaging study. Eur Radiol. 2015; 25(6): 1684–91. DOI: 10.1007/s00330-014-3571-5Breidthardt T., Cox E.F., Squire I., Odudu A., Omar N.F., Eldehni M.T. et al. The pathophysiology of the chronic cardiorenal syndrome: a magnetic resonance imaging study. Eur Radiol. 2015; 25(6): 1684–91. DOI: 10.1007/s00330-014-3571-5Iida N., Seo Y., Sai S., Machino-Ohtsuka T, Yamamoto M, Ishizu T et al. Clinical Implications of Intrarenal Hemodynamic Evaluation by Doppler Ultrasonography in Heart Failure. JACC Heart Fail. 2016; 4(8): 674–82. DOI: 10.1016/j.jchf.2016.03.016Iida N., Seo Y., Sai S., Machino-Ohtsuka T, Yamamoto M, Ishizu T et al. Clinical Implications of Intrarenal Hemodynamic Evaluation by Doppler Ultrasonography in Heart Failure. JACC Heart Fail. 2016; 4(8): 674–82. DOI: 10.1016/j.jchf.2016.03.016Savira F., Magaye R., Liew D., Reid C., Kelly D.J., Kompa A.R. et al. Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature. Br J Pharmacol. 2020; 177(13): 2906–2922. DOI: 10.1111/bph.15065Savira F., Magaye R., Liew D., Reid C., Kelly D.J., Kompa A.R. et al. Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature. Br J Pharmacol. 2020; 177(13): 2906–2922. DOI: 10.1111/bph.15065Hanberg J.S., Sury K., Wilson F.P., Brisco M.A., Ahmad T., Ter Maaten J.M. et al. Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure. J Am Coll Cardiol. 2016; 67(19): 2199–2208. DOI: 10.1016/j.jacc.2016.02.058Hanberg J.S., Sury K., Wilson F.P., Brisco M.A., Ahmad T., Ter Maaten J.M. et al. Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure. J Am Coll Cardiol. 2016; 67(19): 2199–2208. DOI: 10.1016/j.jacc.2016.02.058Nohria A., Hasselblad V., Stebbins A., Pauly D.F., Fonarow G.C., Shah M. et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008; 51(13): 1268–1274. DOI: 10.1016/j.jacc.2007.08.072Nohria A., Hasselblad V., Stebbins A., Pauly D.F., Fonarow G.C., Shah M. et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008; 51(13): 1268–1274. DOI: 10.1016/j.jacc.2007.08.072Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A. et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006; 355(3): 260–9. DOI: 10.1056/NEJMoa051530Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A. et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006; 355(3): 260–9. DOI: 10.1056/NEJMoa051530Hillege H.L., Girbes A.R., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A. et al. Renal function, neurohor-monal activation, and survival in patients with chronic heart failure. Circulation. 2000; 102(2): 203–10. DOI: 10.1161/01.cir.102.2.203Hillege H.L., Girbes A.R., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A. et al. Renal function, neurohor-monal activation, and survival in patients with chronic heart failure. Circulation. 2000; 102(2): 203–10. DOI: 10.1161/01.cir.102.2.203Liang K.V., Williams A.W., Greene E.L., Redfield M.M. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med. 2008; 36(1): 75–88. DOI: 10.1097/01.CCM.0000296270.41256.5CLiang K.V., Williams A.W., Greene E.L., Redfield M.M. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med. 2008; 36(1): 75–88. DOI: 10.1097/01.CCM.0000296270.41256.5CWang J., Zhang W., Wu L., Mei Y., Cui S., Feng Z. et al. New insights into the pathophysiological mechanisms underlying cardiorenal syndrome. Aging (Albany NY). 2020; 12(12): 12422–12431. DOI: 10.18632/aging.103354Wang J., Zhang W., Wu L., Mei Y., Cui S., Feng Z. et al. New insights into the pathophysiological mechanisms underlying cardiorenal syndrome. Aging (Albany NY). 2020; 12(12): 12422–12431. DOI: 10.18632/aging.103354Арутюнов А.Г., Башкинов Р.А., Батлук Т.И., Мельников Е.С., Ермилова А.Н. Острое повреждение почек у пациентов с хронической сердечной недостаточностью. Южно-Российский журнал терапевтической практики. 2021; 2(3): 6–17. DOI: 10.21886/2712-8156-2021-2-3-6-17Arutyunov A.G., Bashkinov R.A., Batluk T.I., Melnikov E.S., Ermilova A.N. Acute kidney injury in patients with chronic heart failure. Yuzhno-Rossijskij zhurnal terapevticheskoj praktiki.2021; 2(3): 6–17 (in Russ.). DOI: 10.21886/2712-8156-2021-2-3-6-17Makaritsis K.P., Liakopoulos V., Leivaditis K., Eleftheriadis T., Stefanidis I. Adaptation of renal function in heart failure. Ren Fail. 2006; 28(7): 527–35. DOI: 10.1080/08860220600839522Makaritsis K.P., Liakopoulos V., Leivaditis K., Eleftheriadis T., Stefanidis I. Adaptation of renal function in heart failure. Ren Fail. 2006; 28(7): 527–35. DOI: 10.1080/08860220600839522Bongartz L.G., Cramer M.J., Doevendans P.A., Joles J.A., Braam B. The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J. 2005; 26(1): 11–7. DOI: 10.1093/eurheartj/ehi020Bongartz L.G., Cramer M.J., Doevendans P.A., Joles J.A., Braam B. The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J. 2005; 26(1): 11–7. DOI: 10.1093/eurheartj/ehi020Hostetter T.H., Ibrahim H.N. Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol. 2003; 14(9): 2395– 401. DOI: 10.1097/01.asn.0000086472.65806.73Hostetter T.H., Ibrahim H.N. Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol. 2003; 14(9): 2395– 401. DOI: 10.1097/01.asn.0000086472.65806.73Lin L., Zhou X., Dekkers I.A., Lamb H.J. Cardiorenal Syndrome: Emerging Role of Medical Imaging for Clinical Diagnosis and Management. J Pers Med. 2021; 11(8): 734. DOI: 10.3390/jpm11080734Lin L., Zhou X., Dekkers I.A., Lamb H.J. Cardiorenal Syndrome: Emerging Role of Medical Imaging for Clinical Diagnosis and Management. J Pers Med. 2021; 11(8): 734. DOI: 10.3390/jpm11080734McCullough P.A., Li S., Jurkovitz C.T., Stevens L.A., Wang C., Collins A.J. et al. Kidney Early Evaluation Program Investigators. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis. 2008; 51(4): 38–45. DOI: 10.1053/j.ajkd.2007.12.017McCullough P.A., Li S., Jurkovitz C.T., Stevens L.A., Wang C., Collins A.J. et al. Kidney Early Evaluation Program Investigators. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis. 2008; 51(4): 38–45. DOI: 10.1053/j.ajkd.2007.12.017Leventoğlu E., Kavgacı A., Örün U.A., Büyükkaragöz B. Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome. Cardiorenal Med. 2025; 15: 358–373. DOI: 10.1159/000545791Leventoğlu E., Kavgacı A., Örün U.A., Büyükkaragöz B. Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome. Cardiorenal Med. 2025; 15: 358–373. DOI: 10.1159/000545791Van den Eynde J., Rotbi H., Gewillig M., Kutty S., Allegaert K., Mekahli D. In-Hospital Outcomes of Acute Kidney Injury After Pediatric Cardiac Surgery: A Meta-Analysis. Front Pediatr. 2021;9:733744. DOI: 10.3389/fped.2021.733744Van den Eynde J., Rotbi H., Gewillig M., Kutty S., Allegaert K., Mekahli D. In-Hospital Outcomes of Acute Kidney Injury After Pediatric Cardiac Surgery: A Meta-Analysis. Front Pediatr. 2021;9:733744. DOI: 10.3389/fped.2021.733744Сергеев С.А., Ломиворотов В.В. Острое повреждение почек у детей после кардиохирургических вмешательств. Патология кровообращения и кардиохирургия. 2021; 25(4): 11–22. DOI: 10.21688/1681-3472-2021-4-11-22Sergeev S.A., Lomivorotov V.V. Acute kidney injury after cardiac surgery in children. Patologiya krovoobrashcheniya i kardiohirurgiya. 2021; 25(4): 11–22. (in Russ.). DOI: 10.21688/1681-3472-2021-4-11-22Leventoğlu E., Kavgacı A., Örün Ua, Büyükkaragöz B. Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome. Cardiorenal Med. 2025; 15: 358–373. DOI: 10.1159/000545791Leventoğlu E., Kavgacı A., Örün Ua, Büyükkaragöz B. Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome. Cardiorenal Med. 2025; 15: 358–373. DOI: 10.1159/000545791

The authors declare that there are no conflicts of interest present.